DNA-based delivery of incretin receptor agonists using MYO Technology leads to durable weight loss in a diet-induced obesity model.
Overview
- RenBio Inc., Long Island City, New York, NY 11101, USA
- Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA 70803, USA
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.
The paper's code and data availability statement is in the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.
Data
No dataset and no data link were found in the paper.
Code and data availability statement
The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- it says that the data are available on request
- it says that the code is available on request
Read it in the paper: doi.org/10.1016/j.omtn.2026.102946.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 11 authors, 11 keywords, 1 funder, 57 references.
Cite
This paper
Sasset, L., Cameron, A. D., Sussman, C., Rubinelli, L., Maji, D., Miller, R., Thompson, A., Campbell, D., Walker, M. R., Drozdz, M. M., & Liberatore, R. A. (2026). DNA-based delivery of incretin receptor agonists using MYO Technology leads to durable weight loss in a diet-induced obesity model. Molecular therapy. Nucleic acids, 37(2), 102946. https://
BibTeX
@article{sasset2026dna,
author = {Sasset, Linda and Cameron, Andrew D. and Sussman, Carleigh and Rubinelli, Luisa and Maji, Debnath and Miller, Robert and Thompson, Andy and Campbell, Delcora and Walker, Melanie R. and Drozdz, Marek M. and Liberatore, Rachel A.},
title = {{DNA-based delivery of incretin receptor agonists using MYO Technology leads to durable weight loss in a diet-induced obesity model}},
journal = {Molecular therapy. Nucleic acids},
year = {2026},
month = may,
volume = {37},
number = {2},
pages = {102946},
publisher = {American Society of Gene \& Cell Therapy},
issn = {2162-2531},
doi = {10.1016/
url = {https://
pmid = {42211692},
pmcid = {PMC13213231}
}
RIS
TY - JOUR
AU - Sasset, Linda
AU - Cameron, Andrew D.
AU - Sussman, Carleigh
AU - Rubinelli, Luisa
AU - Maji, Debnath
AU - Miller, Robert
AU - Thompson, Andy
AU - Campbell, Delcora
AU - Walker, Melanie R.
AU - Drozdz, Marek M.
AU - Liberatore, Rachel A.
TI - DNA-based delivery of incretin receptor agonists using MYO Technology leads to durable weight loss in a diet-induced obesity model
T2 - Molecular therapy. Nucleic acids
J2 - Mol Ther Nucleic Acids
PY - 2026
DA - 2026/
VL - 37
IS - 2
SP - 102946
SN - 2162-2531
PB - American Society of Gene & Cell Therapy
DO - 10.1016/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1016/
"type": "article-journal",
"title": "DNA-based delivery of incretin receptor agonists using MYO Technology leads to durable weight loss in a diet-induced obesity model",
"container-title": "Molecular therapy. Nucleic acids",
"author": [
{
"family": "Sasset",
"given": "Linda"
},
{
"family": "Cameron",
"given": "Andrew D."
},
{
"family": "Sussman",
"given": "Carleigh"
},
{
"family": "Rubinelli",
"given": "Luisa"
},
{
"family": "Maji",
"given": "Debnath"
},
{
"family": "Miller",
"given": "Robert"
},
{
"family": "Thompson",
"given": "Andy"
},
{
"family": "Campbell",
"given": "Delcora"
},
{
"family": "Walker",
"given": "Melanie R."
},
{
"family": "Drozdz",
"given": "Marek M."
},
{
"family": "Liberatore",
"given": "Rachel A."
}
],
"container-title-short":
"volume": "37",
"issue": "2",
"page": "102946",
"DOI": "10.1016/
"PMID": "42211692",
"PMCID": "PMC13213231",
"ISSN": "2162-2531",
"publisher": "American Society of Gene & Cell Therapy",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
1
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41586-026-10444-4 [code]
- A brain reward circuit inhibited by next-generation weight-loss drugs in mice.Journal: NatureIn common: 3 references
- [2] doi:10.1038/s41467-026-76688-w [code]
- Transcriptome profiling of human hypothalamic agouti-related protein and proopiomelanocortin neurons regulating energy homeostasis.Journal: Nature communicationsIn common: cellular / molecular, 2 references
- [3] doi:10.1080/10717544.2026.2660007
- Angiopep-2-decorated bacterial outer membrane vesicles penetrate the blood-brain barrier for glioblastoma chemo-immunotherapy.Journal: Drug deliveryIn common: other condition, cellular / molecular, 1 reference
- [4] doi:10.1002/alz.71471 [code]
- How does type 2 diabetes modify the risk of Alzheimer's disease?Journal: Alzheimer's & dementia : the journal of the Alzheimer's AssociationIn common: other condition, cellular / molecular, 1 reference
- [5] doi:10.64898/2026.05.13.26353120 [code]
- WITHDRAWN: Can glucagon like peptide-1 receptor agonists be beneficial for brain health?Journal: medRxiv (preprint)In common: cellular / molecular, 1 reference
- [6] doi:10.3389/fragi.2026.1856979 [code]
- A minimal three-arm oral regimen for healthspan: mechanistic alignment with transcriptomic signals from a large parental-lifespan GWAS.Journal: Frontiers in agingIn common: cellular / molecular, 1 reference
- [7] doi:10.1038/s41467-026-74038-4 [code]
- Semaglutide attenuates neuroinflammation in male mice.Journal: Nature communicationsIn common: cellular / molecular, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.